MARK2 Antibody (3B12)
Novus Biologicals, part of Bio-Techne | Catalog # H00002011-M01
![ELISA: MARK2 Antibody (3B12) [H00002011-M01]](https://resources.bio-techne.com/images/products/MARK2-Antibody-3B12-ELISA-H00002011-M01-img0011.jpg "ELISA: MARK2 Antibody (3B12) [H00002011-M01]")
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Cited:
Human
Applications
Validated:
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Cited:
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # 3B12
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
MARK2 (AAH08771, 401 a.a. ~ 500 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. QAAGPAIPTSNSYSKKTQSNNAENKRPEEDRESGRKASSTAKVPASPLPGLERKKTTPTPSTNSVLSTSTNRSRNSPLLERASLGQASIQNGKDSLTMPG
Reactivity Notes
Please note that this antibody is reactive to Mouse and derived from the same host, Mouse. Additional Mouse on Mouse blocking steps may be required for IHC and ICC experiments. Please contact Technical Support for more information.
Specificity
MARK2 - MAP/microtubule affinity-regulating kinase 2
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Description
Quality control test: Antibody Reactive Against Recombinant Protein.
Scientific Data Images for MARK2 Antibody (3B12)
![Western Blot: MARK2 Antibody (3B12) [H00002011-M01]](https://resources.bio-techne.com/images/products/MARK2-Antibody-3B12-Western-Blot-H00002011-M01-img0010.jpg "Western Blot: MARK2 Antibody (3B12) [H00002011-M01]")
Western Blot: MARK2 Antibody (3B12) [H00002011-M01]
Western Blot: MARK2 Antibody (3B12) [H00002011-M01] - MARK2 monoclonal antibody (M01), clone 3B12. Analysis of MARK2 expression in NIH/3T3.![Western Blot: MARK2 Antibody (3B12) [H00002011-M01]](https://resources.bio-techne.com/images/products/MARK2-Antibody-3B12-Western-Blot-H00002011-M01-img0008.jpg "Western Blot: MARK2 Antibody (3B12) [H00002011-M01]")
Western Blot: MARK2 Antibody (3B12) [H00002011-M01]
Western Blot: MARK2 Antibody (3B12) [H00002011-M01] - MARK2 monoclonal antibody (M01), clone 3B12. Analysis of MARK2 expression in PC-12.![Western Blot: MARK2 Antibody (3B12) [H00002011-M01]](https://resources.bio-techne.com/images/products/MARK2-Antibody-3B12-Western-Blot-H00002011-M01-img0009.jpg "Western Blot: MARK2 Antibody (3B12) [H00002011-M01]")
Western Blot: MARK2 Antibody (3B12) [H00002011-M01]
Western Blot: MARK2 Antibody (3B12) [H00002011-M01] - MARK2 monoclonal antibody (M01), clone 3B12. Analysis of MARK2 expression in A-431.Applications for MARK2 Antibody (3B12)
Application
Recommended Usage
Western Blot
1:500-1:1000
Application Notes
Use in Immunocytochemistry/immunofluorescence reported in scientific literature (PMID: 29941476).
Formulation, Preparation, and Storage
Purification
IgG purified
Formulation
In 1x PBS, pH 7.4
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Background: MARK2
Alternate Names
EC 2.7.11, EC 2.7.11.1, ELKL motif kinase, ELKL motif kinase 1, EMK-1, EMK1PAR-1, MAP/microtubule affinity-regulating kinase 2MGC99619, PAR1 homolog, Par1b, Ser/Thr protein kinase PAR-1B, serine/threonine protein kinase EMK, serine/threonine-protein kinase MARK2
Entrez Gene IDs
2011 (Human)
Gene Symbol
MARK2
OMIM
600526 (Human)
UniProt
Additional MARK2 Products
Product Documents for MARK2 Antibody (3B12)
Product Specific Notices for MARK2 Antibody (3B12)
This product is produced by and distributed for Abnova, a company based in Taiwan.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...